Triplex is an immune-preventive HER-2/neu breast cancer vaccine comprising two non-antigen specific adjuvants (IL-12 and allogeneic major histocompatibility complex (MHC) class I molecules) in addition to the specific target antigen, p185 (HER-2/neu). This evidence concerns the gene ERBB2 and breast cancer.